CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 40 filers reported holding CTI BIOPHARMA CORP in Q3 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $83,000 | -8.8% | 28,400 | 0.0% | 0.00% | – |
| Q4 2020 | $91,000 | +49.2% | 28,400 | 0.0% | 0.00% | – |
| Q3 2020 | $61,000 | +84.8% | 28,400 | 0.0% | 0.00% | – |
| Q2 2020 | $33,000 | +26.9% | 28,400 | 0.0% | 0.00% | – |
| Q1 2020 | $26,000 | -42.2% | 28,400 | 0.0% | 0.00% | – |
| Q4 2019 | $45,000 | +87.5% | 28,400 | 0.0% | 0.00% | – |
| Q3 2019 | $24,000 | 0.0% | 28,400 | 0.0% | 0.00% | – |
| Q2 2019 | $24,000 | -14.3% | 28,400 | 0.0% | 0.00% | – |
| Q1 2019 | $28,000 | +33.3% | 28,400 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -65.6% | 28,400 | 0.0% | 0.00% | – |
| Q3 2018 | $61,000 | -56.7% | 28,400 | 0.0% | 0.00% | – |
| Q2 2018 | $141,000 | +27.0% | 28,400 | 0.0% | 0.00% | – |
| Q1 2018 | $111,000 | +46.1% | 28,400 | 0.0% | 0.00% | – |
| Q4 2017 | $76,000 | -16.5% | 28,400 | 0.0% | 0.00% | – |
| Q3 2017 | $91,000 | -3.2% | 28,400 | 0.0% | 0.00% | – |
| Q2 2017 | $94,000 | -21.0% | 28,400 | 0.0% | 0.00% | – |
| Q1 2017 | $119,000 | – | 28,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |